Data as of Q4 2025 (Dec 31, 2025)

Elmind Capital, LP

โ€ขCIK: 2052213โ€ขFiling: Q4 2025

**Elmind Capital, LP** manages $339M across a concentrated portfolio of 34 positions. The fund exhibits significant conviction in select names, with top holdings including COGT at $41.6M and SNDX at $39.0M. Further notable allocations include VRDN ($26.7M) and VERA ($24.4M), suggesting a focused, high-conviction approach to market opportunities. This structure indicates a tactical deployment of capital within specific sectors.

Total AUM
$338.9M
QoQ Performance
N/A
Positions
34
Top 10 Concentration
68.5%
Latest Filing
Q4 2025

Top Holdings Allocation

COGT
SNDX
VRDN
VERA
TCE2
CGON
COGT12.3%
SNDX11.5%
VRDN7.9%
VERA7.2%
TCE26.9%
CGON6.0%
BCRX4.9%
PCVX4.0%

๐Ÿ“ˆ Biggest Buys

COGT
COGENT BIOSCIENCES INC
NEW
12.3% of portfolio
SNDX
SYNDAX PHARMACEUTICALS INC
NEW
11.5% of portfolio
VRDN
VIRIDIAN THERAPEUTICS INC
NEW
7.9% of portfolio
VERA
VERA THERAPEUTICS INC
NEW
7.2% of portfolio
TCE2
CELLDEX THERAPEUTICS INC NEW
NEW
6.9% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%